查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1466692

核子醫學市場：按產品、應用、類型和最終用戶 - 2024-2030 年全球預測

Nuclear Medicine Market by Product (Diagnostic Products, Therapeutic Products), Application (Bone Metastasis, Cardiology, Endocrine Tumor), Type, End-Users - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 184 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計2023年核醫市場規模為51.4億美元，預計2024年將達55.1億美元，2030年將達84.5億美元，複合年成長率為7.35%。

核子醫學市場是指涉及使用和生產用於醫學影像診斷和治療的放射性同位素的醫療保健產業。核子醫學市場包括用於診斷影像的診斷放射性藥物，例如正子斷層掃描（PET）和單光子發射斷層掃描（SPECT），以及用於治療各種疾病的治療性放射性藥物。成像技術的進步和新型放射性藥物的開發正在影響市場的開拓。需要精確診斷技術的慢性疾病的日益流行增加了對核醫學的需求。患者和醫療保健提供者對核醫學的認知和接受度的提高有助於市場的成長。然而，嚴格的監管障礙和高昂的產品開發成本限制了核子醫學的採用。診斷影像設備和專業設施所需的高資本投資是一個市場挑戰。此外，更安全、更有效的新型放射性同位素的生產正在吸引巨大的市場成長機會。將診斷和治療能力整合到核製劑中的治療診斷學的出現也創造了市場成長潛力。

主要市場統計
基準年[2023] 51.4億美元
預測年份 [2024] 55.1億美元
預測年份 [2030] 84.5億美元
複合年成長率（%） 7.35%

產品診斷產品在核子醫學的意義

核子醫學診斷產品用於各種疾病的診斷和治療，主要透過檢測引入體內的放射性示蹤劑的輻射。診斷示蹤劑針對特定的器官、骨骼和組織，使醫生能夠了解身體各部位的功能並發現異常。核子醫學中包含的治療產品旨在治療各種癌症和其他疾病。核子醫學領域的治療產品包括含有放射性同位素的放射性藥物，這些放射性藥物特異性針對並摧毀患病細胞，同時最大限度地減少對正常組織的損害。

最終用戶醫院和診斷中心的多功能應用

醫院和診斷中心是核子醫學市場最大的最終用戶。醫院和診斷中心需要診斷影像和標靶治療應用來提供準確、快速的患者照護。研究機構透過探索新的放射性藥物、新的成像技術和尖端治療方法，為核子醫學的發展做出了重大貢獻。

區域洞察

在包括美國和加拿大在內的美洲地區，先進的醫療基礎設施、高昂的醫療成本和豐富的放射性藥物管道正在推動核醫的需求。由於先進診斷技術的早期採用、研發的大量投資以及有利的報銷政策，美國和加拿大仍然是核子醫學最大的地區。歐洲市場的特徵是經濟高度發展、醫療保健體系完善、政府資金投入較多。在歐洲地區，對診斷和治療放射性藥物的需求透過成本控制措施和對實證臨床結果的重視來平衡。在中東地區，阿拉伯聯合大公國（阿拉伯聯合大公國）和沙烏地阿拉伯是主要貢獻者，透過努力改善核醫學服務的可及性，為市場成長做出了貢獻。在亞太地區，由於政府對醫療基礎設施的投資以及癌症和心血管疾病發病率的上升，中國的核子醫學產業正在迅速擴張。由於醫療意識的提高和醫療設施的改善，日本和印度的核醫學領域正在不斷發展。

FPNV定位矩陣

FPNV定位矩陣對於評估核醫市場至關重要。我們檢視與業務策略和產品滿意度相關的關鍵指標，以對供應商進行全面評估。這種深入的分析使用戶能夠根據自己的要求做出明智的決策。根據評估，供應商被分為四個成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市場佔有率分析

市場佔有率分析是一種綜合工具，可以對核醫市場供應商的現狀進行深入而深入的研究。全面比較和分析供應商在整體收益、基本客群和其他關鍵指標方面的貢獻，以便更好地了解公司的績效及其在爭奪市場佔有率時面臨的挑戰。此外，該分析還提供了對該行業競爭特徵的寶貴見解，包括在研究基準年觀察到的累積、分散主導地位和合併特徵等因素。這種詳細程度的提高使供應商能夠做出更明智的決策並制定有效的策略，從而在市場上獲得競爭優勢。

本報告在以下方面提供了寶貴的見解：

1. 市場滲透率：提供有關主要企業所服務的市場的全面資訊。

2. 市場開拓：我們深入研究利潤豐厚的新興市場，並分析其在成熟細分市場的滲透率。

3. 市場多元化：提供有關新產品發布、開拓地區、最新發展和投資的詳細資訊。

4. 競爭評估和情報：對主要企業的市場佔有率、策略、產品、認證、監管狀況、專利狀況和製造能力進行全面評估。

5. 產品開發與創新：提供對未來技術、研發活動和突破性產品開發的見解。

本報告解決了以下關鍵問題：

1.核醫市場規模及預測如何？

2.核醫市場預測期內需要考慮投資的產品、細分市場、應用和領域有哪些？

3.核醫市場的技術趨勢與法規結構是什麼？

4.核醫市場主要廠商的市場佔有率是多少？

5. 進入核醫市場的適當型態和策略手段是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 世界各地的癌症發生率和盛行率正在上升
      • PET 和 SPECT 在診斷心臟和神經系統疾病的使用增加
      • 國際組織的努力與支持核子醫學的認知
    • 抑制因素
      • 核醫學半衰期短
    • 機會
      • 治療治療診斷學在核子醫學中日益普及
      • 持續的產品開發和專利技術進步
    • 任務
      • 新興國家缺乏核子醫學知識、培訓和可用性
      • 全球缺乏熟練的放射科醫生和醫生
  • 市場區隔分析
    • 產品：診斷產品在核子醫學的意義
    • 最終用戶：醫院和診斷中心的各種應用
  • 市場趨勢分析
  • 俄羅斯-烏克蘭衝突的累積影響
  • 高通膨的累積效應
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 法規結構分析
  • 客戶客製化

第6章核子醫學市場：依產品

  • 診斷產品
  • 治療產品

第7章 核子醫學市場：依應用分類

  • 骨轉移
  • 心臟病學
  • 內分泌腫瘤
  • 淋巴瘤
  • 腫瘤學
  • 甲狀腺

第8章核子醫學市場：依類型

  • 診斷
  • 治療性的

第9章核醫市場：依最終使用者分類

  • 醫院和診斷中心
  • 調查機構

第10章美洲核子醫學市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太核子醫學市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章 歐洲、中東和非洲核子醫學市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • Shine 與 Nucleus RadioPharma 簽署供應協議
    • ITM與加拿大核能研究所成立新公司
    • Life Healthcare 將收購南非核子醫學業務

第14章競爭產品組合

  • 主要企業簡介
  • 主要產品系列
Product Code: MRR-A339DAEFAF4C

[184 Pages Report] The Nuclear Medicine Market size was estimated at USD 5.14 billion in 2023 and expected to reach USD 5.51 billion in 2024, at a CAGR 7.35% to reach USD 8.45 billion by 2030.

The nuclear medicine market refers to the healthcare industry concerned with the use and production of radioisotopes for medical imaging and therapy. The nuclear medicine market includes diagnostic radiopharmaceuticals used in imaging procedures including positron emission tomography (PET) and single-photon emission computed tomography (SPECT), as well as therapeutic radiopharmaceuticals for the treatment of various conditions. The advancements in imaging technologies and the development of new radiopharmaceuticals is influencing the market growth. The rising prevalence of chronic diseases requiring precise diagnostic techniques is enhancing the need for nuclear medicines. The increased awareness and acceptance of nuclear medicine procedures among patients and healthcare providers is contributing to market growth. However, stringent regulatory barriers and the high cost of product development has limited the adoption of nuclear medicines. High capital investment required for imaging equipment and specialized facilities is a challenging factor for the market. Moreover, manufacturing of novel radioisotopes with safer profiles and higher efficacy is attracting significant opportunities for market growth. The emergence of theranostics, integrating diagnostic and therapeutic capabilities within nuclear agents is also generating growth potential in the market.

KEY MARKET STATISTICS
Base Year [2023] USD 5.14 billion
Estimated Year [2024] USD 5.51 billion
Forecast Year [2030] USD 8.45 billion
CAGR (%) 7.35%

Product: Significance of diagnostic products in nuclear medicines

Diagnostic products in nuclear medicine are primarily used to diagnose and manage various diseases by detecting the radiation from a radioactive tracer that is introduced into the body. Diagnostic tracers target specific organs, bones, or tissues, allowing physicians to see how body parts function and detect anomalies. Therapeutic products in nuclear medicine are designed to treat various cancers and other diseases. Therapeutic products in nuclear medicine involve radiopharmaceuticals containing radioactive isotopes that specifically target and destroy diseased cells while minimizing damage to normal tissues.

End-Users: Diverse applications in hospitals and diagnostic centers

The hospitals, and diagnostic centers represent the largest end-user segment in the nuclear medicine market. Hospitals & diagnostic centers need diagnostic imaging and targeted therapeutic applications to provide accurate and prompt patient care. Research institutes significantly contribute to advancing nuclear medicine by exploring new radiopharmaceuticals, novel imaging techniques, and cutting-edge therapeutic methods.

Regional Insights

In the Americas region, the United States and Canada, the demand for nuclear medicine is driven by a sophisticated healthcare infrastructure, high healthcare expenditure, and a robust pipeline of radiopharmaceuticals. The United States and Canada remain the largest region for nuclear medicine due to its early adoption of advanced diagnostics, substantial investment in research and development, and favorable reimbursement policies. The European market is characterized by a high level of economic development, a well-established healthcare system, and significant government funding. In the European region, the demand for diagnostic and therapeutic radiopharmaceuticals is balanced by cost-containment measures and emphasis on evidence-based clinical outcomes. The United Arab Emirates (UAE) and Saudi Arabia are key contributors in the Middle East region, contributing to the market growth, with initiatives to increase accessibility to nuclear medical services. In the APAC region, china's nuclear medicine sector is rapidly expanding, due to government investment in healthcare infrastructure and an increasing incidence of cancer and cardiovascular diseases. Japan and India's nuclear medicine sector is growing due to rising healthcare awareness and improvements in healthcare facilities.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Nuclear Medicine Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Nuclear Medicine Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Nuclear Medicine Market, highlighting leading vendors and their innovative profiles. These include Actinium Pharmaceuticals, Inc., Bayer AG, BJ Madan & Co., Bracco S.p.A., BWX Technologies, Inc. by Framatome, Cardinal Health, Inc., Curium, Eckert & Ziegler Radiopharma GmbH, Eczacibasi Monrol Nuclear Products Co., GE Healthcare, IBA Radiopharma Solutions, Institute of Isotopes Co., Ltd., Isotope Joint Stock Company, Isotopia Molecular Imaging, Jubilant DraxImage, Inc., Lantheus Holdings, Inc., Nordic Nanovector ASA by Thor Medical, Nordion (Canada) Inc. by Sotera Health LLC, Northstar Medical Technologies LLC, Novartis AG, NTP Radioisotopes SOC Ltd., PharmaLogic Holdings LLC, Radiopharm Theranostics Limited, SHINE Technologies, LLC, and Sinotau Pharmaceuticals Group.

Market Segmentation & Coverage

This research report categorizes the Nuclear Medicine Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Product
    • Diagnostic Products
      • PET
        • F-18
        • SR-82/RB-82
      • SPECT
        • GA-67
        • I-123
        • TC-99m
        • TL-201
    • Therapeutic Products
      • Alpha Emitters
      • Beta Emitters
        • I-131
        • Lu-117
        • Re-186
        • SM-153
        • Y-90
      • Brachytherapy
        • Cesium-131
        • Iodine-125
        • Iridium-192
        • Palladium-103
  • Application
    • Bone Metastasis
    • Cardiology
    • Endocrine Tumor
    • Lymphoma
    • Oncology
    • Thyroid
  • Type
    • Diagnostic
      • PET Procedures
      • SPECT Procedures
    • Therapeutic
      • Alpha Emitter Procedures
      • Beta Emitter Procedures
      • Brachytherapy Procedures
  • End-Users
    • Hospitals & Diagnostic Centers
    • Research institutes
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Nuclear Medicine Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Nuclear Medicine Market?

3. What are the technology trends and regulatory frameworks in the Nuclear Medicine Market?

4. What is the market share of the leading vendors in the Nuclear Medicine Market?

5. Which modes and strategic moves are suitable for entering the Nuclear Medicine Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising Incidence and Prevalence of Cancer Worldwide
      • 5.1.1.2. Increasing Use of PET and SPECT to Diagnose Heart disease and Neurological Disorders
      • 5.1.1.3. International Organizations' Initiatives and Awareness Supporting Nuclear Medicine
    • 5.1.2. Restraints
      • 5.1.2.1. Shorter Half-Life of Nuclear Medicine
    • 5.1.3. Opportunities
      • 5.1.3.1. Emerging Popularity of Theranostics in Nuclear Medicine
      • 5.1.3.2. Continuous Product Developments and Advancements in Patented Technologies
    • 5.1.4. Challenges
      • 5.1.4.1. Lack of Knowledge, Training, and Availability of Nuclear Medicine in Developing Countries
      • 5.1.4.2. Limited Availability of Skilled Radiologists and Practitioners Worldwide
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Significance of diagnostic products in nuclear medicines
    • 5.2.2. End-Users: Diverse applications in hospitals and diagnostic centers
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of Russia-Ukraine Conflict
  • 5.5. Cumulative Impact of High Inflation
  • 5.6. Porter's Five Forces Analysis
    • 5.6.1. Threat of New Entrants
    • 5.6.2. Threat of Substitutes
    • 5.6.3. Bargaining Power of Customers
    • 5.6.4. Bargaining Power of Suppliers
    • 5.6.5. Industry Rivalry
  • 5.7. Value Chain & Critical Path Analysis
  • 5.8. Regulatory Framework Analysis
  • 5.9. Client Customization

6. Nuclear Medicine Market, by Product

  • 6.1. Introduction
  • 6.2. Diagnostic Products
  • 6.3. Therapeutic Products

7. Nuclear Medicine Market, by Application

  • 7.1. Introduction
  • 7.2. Bone Metastasis
  • 7.3. Cardiology
  • 7.4. Endocrine Tumor
  • 7.5. Lymphoma
  • 7.6. Oncology
  • 7.7. Thyroid

8. Nuclear Medicine Market, by Type

  • 8.1. Introduction
  • 8.2. Diagnostic
  • 8.3. Therapeutic

9. Nuclear Medicine Market, by End-Users

  • 9.1. Introduction
  • 9.2. Hospitals & Diagnostic Centers
  • 9.3. Research institutes

10. Americas Nuclear Medicine Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Nuclear Medicine Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Nuclear Medicine Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Shine Reaches Supply Agreement with Nucleus RadioPharma
    • 13.3.2. ITM and Canadian Nuclear Labs Launch New Company
    • 13.3.3. Life Healthcare Set to Acquire Nuclear-medicine Operation in SA

14. Competitive Portfolio

  • 14.1. Key Company Profiles
  • 14.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. NUCLEAR MEDICINE MARKET RESEARCH PROCESS
  • FIGURE 2. NUCLEAR MEDICINE MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL NUCLEAR MEDICINE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. NUCLEAR MEDICINE MARKET DYNAMICS
  • FIGURE 7. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY END-USERS, 2023 VS 2030 (%)
  • FIGURE 14. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY END-USERS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. AMERICAS NUCLEAR MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 16. AMERICAS NUCLEAR MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 18. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. ASIA-PACIFIC NUCLEAR MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. ASIA-PACIFIC NUCLEAR MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 23. NUCLEAR MEDICINE MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 24. NUCLEAR MEDICINE MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. NUCLEAR MEDICINE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL NUCLEAR MEDICINE MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL NUCLEAR MEDICINE MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PRODUCTS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PRODUCTS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PRODUCTS, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PRODUCTS, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY PET, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY PET, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY PET, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY PET, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY F-18, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY F-18, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY SR-82/RB-82, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY SR-82/RB-82, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY SPECT, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY SPECT, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY SPECT, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY SPECT, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY GA-67, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY GA-67, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY I-123, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY I-123, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 29. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY TC-99M, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 30. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY TC-99M, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 31. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY TL-201, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 32. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY TL-201, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 33. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC PRODUCTS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 34. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC PRODUCTS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 35. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2018-2023 (USD MILLION)
  • TABLE 36. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2024-2030 (USD MILLION)
  • TABLE 37. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY ALPHA EMITTERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 38. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY ALPHA EMITTERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 39. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 40. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 41. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTERS, 2018-2023 (USD MILLION)
  • TABLE 42. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTERS, 2024-2030 (USD MILLION)
  • TABLE 43. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY I-131, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 44. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY I-131, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 45. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY LU-117, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 46. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY LU-117, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 47. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY RE-186, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 48. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY RE-186, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 49. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY SM-153, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 50. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY SM-153, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 51. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY Y-90, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 52. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY Y-90, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 53. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 54. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 55. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY, 2018-2023 (USD MILLION)
  • TABLE 56. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY, 2024-2030 (USD MILLION)
  • TABLE 57. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY CESIUM-131, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 58. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY CESIUM-131, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 59. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY IODINE-125, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 60. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY IODINE-125, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 61. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY IRIDIUM-192, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 62. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY IRIDIUM-192, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 63. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY PALLADIUM-103, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 64. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY PALLADIUM-103, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 65. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 66. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 67. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY BONE METASTASIS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 68. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY BONE METASTASIS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 69. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 70. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY CARDIOLOGY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 71. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY ENDOCRINE TUMOR, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 72. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY ENDOCRINE TUMOR, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 73. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY LYMPHOMA, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 74. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY LYMPHOMA, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 75. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 76. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY ONCOLOGY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 77. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY THYROID, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 78. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY THYROID, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 79. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 80. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 81. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 82. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 83. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC, 2018-2023 (USD MILLION)
  • TABLE 84. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC, 2024-2030 (USD MILLION)
  • TABLE 85. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY PET PROCEDURES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 86. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY PET PROCEDURES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 87. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY SPECT PROCEDURES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 88. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY SPECT PROCEDURES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 89. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 90. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 91. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC, 2018-2023 (USD MILLION)
  • TABLE 92. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC, 2024-2030 (USD MILLION)
  • TABLE 93. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY ALPHA EMITTER PROCEDURES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 94. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY ALPHA EMITTER PROCEDURES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 95. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTER PROCEDURES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 96. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTER PROCEDURES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 97. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY PROCEDURES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 98. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY PROCEDURES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 99. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 100. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 101. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY HOSPITALS & DIAGNOSTIC CENTERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 102. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY HOSPITALS & DIAGNOSTIC CENTERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 103. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 104. GLOBAL NUCLEAR MEDICINE MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 105. AMERICAS NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 106. AMERICAS NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 107. AMERICAS NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PRODUCTS, 2018-2023 (USD MILLION)
  • TABLE 108. AMERICAS NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PRODUCTS, 2024-2030 (USD MILLION)
  • TABLE 109. AMERICAS NUCLEAR MEDICINE MARKET SIZE, BY PET, 2018-2023 (USD MILLION)
  • TABLE 110. AMERICAS NUCLEAR MEDICINE MARKET SIZE, BY PET, 2024-2030 (USD MILLION)
  • TABLE 111. AMERICAS NUCLEAR MEDICINE MARKET SIZE, BY SPECT, 2018-2023 (USD MILLION)
  • TABLE 112. AMERICAS NUCLEAR MEDICINE MARKET SIZE, BY SPECT, 2024-2030 (USD MILLION)
  • TABLE 113. AMERICAS NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2018-2023 (USD MILLION)
  • TABLE 114. AMERICAS NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2024-2030 (USD MILLION)
  • TABLE 115. AMERICAS NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTERS, 2018-2023 (USD MILLION)
  • TABLE 116. AMERICAS NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTERS, 2024-2030 (USD MILLION)
  • TABLE 117. AMERICAS NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY, 2018-2023 (USD MILLION)
  • TABLE 118. AMERICAS NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY, 2024-2030 (USD MILLION)
  • TABLE 119. AMERICAS NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 120. AMERICAS NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 121. AMERICAS NUCLEAR MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 122. AMERICAS NUCLEAR MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 123. AMERICAS NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC, 2018-2023 (USD MILLION)
  • TABLE 124. AMERICAS NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC, 2024-2030 (USD MILLION)
  • TABLE 125. AMERICAS NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC, 2018-2023 (USD MILLION)
  • TABLE 126. AMERICAS NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC, 2024-2030 (USD MILLION)
  • TABLE 127. AMERICAS NUCLEAR MEDICINE MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 128. AMERICAS NUCLEAR MEDICINE MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 129. AMERICAS NUCLEAR MEDICINE MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 130. AMERICAS NUCLEAR MEDICINE MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 131. ARGENTINA NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 132. ARGENTINA NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 133. ARGENTINA NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PRODUCTS, 2018-2023 (USD MILLION)
  • TABLE 134. ARGENTINA NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PRODUCTS, 2024-2030 (USD MILLION)
  • TABLE 135. ARGENTINA NUCLEAR MEDICINE MARKET SIZE, BY PET, 2018-2023 (USD MILLION)
  • TABLE 136. ARGENTINA NUCLEAR MEDICINE MARKET SIZE, BY PET, 2024-2030 (USD MILLION)
  • TABLE 137. ARGENTINA NUCLEAR MEDICINE MARKET SIZE, BY SPECT, 2018-2023 (USD MILLION)
  • TABLE 138. ARGENTINA NUCLEAR MEDICINE MARKET SIZE, BY SPECT, 2024-2030 (USD MILLION)
  • TABLE 139. ARGENTINA NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2018-2023 (USD MILLION)
  • TABLE 140. ARGENTINA NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2024-2030 (USD MILLION)
  • TABLE 141. ARGENTINA NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTERS, 2018-2023 (USD MILLION)
  • TABLE 142. ARGENTINA NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTERS, 2024-2030 (USD MILLION)
  • TABLE 143. ARGENTINA NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY, 2018-2023 (USD MILLION)
  • TABLE 144. ARGENTINA NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY, 2024-2030 (USD MILLION)
  • TABLE 145. ARGENTINA NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 146. ARGENTINA NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 147. ARGENTINA NUCLEAR MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 148. ARGENTINA NUCLEAR MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 149. ARGENTINA NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC, 2018-2023 (USD MILLION)
  • TABLE 150. ARGENTINA NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC, 2024-2030 (USD MILLION)
  • TABLE 151. ARGENTINA NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC, 2018-2023 (USD MILLION)
  • TABLE 152. ARGENTINA NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC, 2024-2030 (USD MILLION)
  • TABLE 153. ARGENTINA NUCLEAR MEDICINE MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 154. ARGENTINA NUCLEAR MEDICINE MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 155. BRAZIL NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 156. BRAZIL NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 157. BRAZIL NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PRODUCTS, 2018-2023 (USD MILLION)
  • TABLE 158. BRAZIL NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PRODUCTS, 2024-2030 (USD MILLION)
  • TABLE 159. BRAZIL NUCLEAR MEDICINE MARKET SIZE, BY PET, 2018-2023 (USD MILLION)
  • TABLE 160. BRAZIL NUCLEAR MEDICINE MARKET SIZE, BY PET, 2024-2030 (USD MILLION)
  • TABLE 161. BRAZIL NUCLEAR MEDICINE MARKET SIZE, BY SPECT, 2018-2023 (USD MILLION)
  • TABLE 162. BRAZIL NUCLEAR MEDICINE MARKET SIZE, BY SPECT, 2024-2030 (USD MILLION)
  • TABLE 163. BRAZIL NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2018-2023 (USD MILLION)
  • TABLE 164. BRAZIL NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2024-2030 (USD MILLION)
  • TABLE 165. BRAZIL NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTERS, 2018-2023 (USD MILLION)
  • TABLE 166. BRAZIL NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTERS, 2024-2030 (USD MILLION)
  • TABLE 167. BRAZIL NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY, 2018-2023 (USD MILLION)
  • TABLE 168. BRAZIL NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY, 2024-2030 (USD MILLION)
  • TABLE 169. BRAZIL NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 170. BRAZIL NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 171. BRAZIL NUCLEAR MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 172. BRAZIL NUCLEAR MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 173. BRAZIL NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC, 2018-2023 (USD MILLION)
  • TABLE 174. BRAZIL NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC, 2024-2030 (USD MILLION)
  • TABLE 175. BRAZIL NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC, 2018-2023 (USD MILLION)
  • TABLE 176. BRAZIL NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC, 2024-2030 (USD MILLION)
  • TABLE 177. BRAZIL NUCLEAR MEDICINE MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 178. BRAZIL NUCLEAR MEDICINE MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 179. CANADA NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 180. CANADA NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 181. CANADA NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PRODUCTS, 2018-2023 (USD MILLION)
  • TABLE 182. CANADA NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PRODUCTS, 2024-2030 (USD MILLION)
  • TABLE 183. CANADA NUCLEAR MEDICINE MARKET SIZE, BY PET, 2018-2023 (USD MILLION)
  • TABLE 184. CANADA NUCLEAR MEDICINE MARKET SIZE, BY PET, 2024-2030 (USD MILLION)
  • TABLE 185. CANADA NUCLEAR MEDICINE MARKET SIZE, BY SPECT, 2018-2023 (USD MILLION)
  • TABLE 186. CANADA NUCLEAR MEDICINE MARKET SIZE, BY SPECT, 2024-2030 (USD MILLION)
  • TABLE 187. CANADA NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2018-2023 (USD MILLION)
  • TABLE 188. CANADA NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2024-2030 (USD MILLION)
  • TABLE 189. CANADA NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTERS, 2018-2023 (USD MILLION)
  • TABLE 190. CANADA NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTERS, 2024-2030 (USD MILLION)
  • TABLE 191. CANADA NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY, 2018-2023 (USD MILLION)
  • TABLE 192. CANADA NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY, 2024-2030 (USD MILLION)
  • TABLE 193. CANADA NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 194. CANADA NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 195. CANADA NUCLEAR MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 196. CANADA NUCLEAR MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 197. CANADA NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC, 2018-2023 (USD MILLION)
  • TABLE 198. CANADA NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC, 2024-2030 (USD MILLION)
  • TABLE 199. CANADA NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC, 2018-2023 (USD MILLION)
  • TABLE 200. CANADA NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC, 2024-2030 (USD MILLION)
  • TABLE 201. CANADA NUCLEAR MEDICINE MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 202. CANADA NUCLEAR MEDICINE MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 203. MEXICO NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 204. MEXICO NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 205. MEXICO NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PRODUCTS, 2018-2023 (USD MILLION)
  • TABLE 206. MEXICO NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PRODUCTS, 2024-2030 (USD MILLION)
  • TABLE 207. MEXICO NUCLEAR MEDICINE MARKET SIZE, BY PET, 2018-2023 (USD MILLION)
  • TABLE 208. MEXICO NUCLEAR MEDICINE MARKET SIZE, BY PET, 2024-2030 (USD MILLION)
  • TABLE 209. MEXICO NUCLEAR MEDICINE MARKET SIZE, BY SPECT, 2018-2023 (USD MILLION)
  • TABLE 210. MEXICO NUCLEAR MEDICINE MARKET SIZE, BY SPECT, 2024-2030 (USD MILLION)
  • TABLE 211. MEXICO NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2018-2023 (USD MILLION)
  • TABLE 212. MEXICO NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2024-2030 (USD MILLION)
  • TABLE 213. MEXICO NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTERS, 2018-2023 (USD MILLION)
  • TABLE 214. MEXICO NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTERS, 2024-2030 (USD MILLION)
  • TABLE 215. MEXICO NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY, 2018-2023 (USD MILLION)
  • TABLE 216. MEXICO NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY, 2024-2030 (USD MILLION)
  • TABLE 217. MEXICO NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 218. MEXICO NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 219. MEXICO NUCLEAR MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 220. MEXICO NUCLEAR MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 221. MEXICO NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC, 2018-2023 (USD MILLION)
  • TABLE 222. MEXICO NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC, 2024-2030 (USD MILLION)
  • TABLE 223. MEXICO NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC, 2018-2023 (USD MILLION)
  • TABLE 224. MEXICO NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC, 2024-2030 (USD MILLION)
  • TABLE 225. MEXICO NUCLEAR MEDICINE MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 226. MEXICO NUCLEAR MEDICINE MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 227. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 228. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 229. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PRODUCTS, 2018-2023 (USD MILLION)
  • TABLE 230. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PRODUCTS, 2024-2030 (USD MILLION)
  • TABLE 231. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY PET, 2018-2023 (USD MILLION)
  • TABLE 232. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY PET, 2024-2030 (USD MILLION)
  • TABLE 233. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY SPECT, 2018-2023 (USD MILLION)
  • TABLE 234. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY SPECT, 2024-2030 (USD MILLION)
  • TABLE 235. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2018-2023 (USD MILLION)
  • TABLE 236. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2024-2030 (USD MILLION)
  • TABLE 237. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTERS, 2018-2023 (USD MILLION)
  • TABLE 238. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTERS, 2024-2030 (USD MILLION)
  • TABLE 239. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY, 2018-2023 (USD MILLION)
  • TABLE 240. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY, 2024-2030 (USD MILLION)
  • TABLE 241. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 242. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 243. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 244. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 245. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC, 2018-2023 (USD MILLION)
  • TABLE 246. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC, 2024-2030 (USD MILLION)
  • TABLE 247. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC, 2018-2023 (USD MILLION)
  • TABLE 248. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC, 2024-2030 (USD MILLION)
  • TABLE 249. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 250. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 251. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 252. UNITED STATES NUCLEAR MEDICINE MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 253. ASIA-PACIFIC NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 254. ASIA-PACIFIC NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 255. ASIA-PACIFIC NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PRODUCTS, 2018-2023 (USD MILLION)
  • TABLE 256. ASIA-PACIFIC NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PRODUCTS, 2024-2030 (USD MILLION)
  • TABLE 257. ASIA-PACIFIC NUCLEAR MEDICINE MARKET SIZE, BY PET, 2018-2023 (USD MILLION)
  • TABLE 258. ASIA-PACIFIC NUCLEAR MEDICINE MARKET SIZE, BY PET, 2024-2030 (USD MILLION)
  • TABLE 259. ASIA-PACIFIC NUCLEAR MEDICINE MARKET SIZE, BY SPECT, 2018-2023 (USD MILLION)
  • TABLE 260. ASIA-PACIFIC NUCLEAR MEDICINE MARKET SIZE, BY SPECT, 2024-2030 (USD MILLION)
  • TABLE 261. ASIA-PACIFIC NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2018-2023 (USD MILLION)
  • TABLE 262. ASIA-PACIFIC NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2024-2030 (USD MILLION)
  • TABLE 263. ASIA-PACIFIC NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTERS, 2018-2023 (USD MILLION)
  • TABLE 264. ASIA-PACIFIC NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTERS, 2024-2030 (USD MILLION)
  • TABLE 265. ASIA-PACIFIC NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY, 2018-2023 (USD MILLION)
  • TABLE 266. ASIA-PACIFIC NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY, 2024-2030 (USD MILLION)
  • TABLE 267. ASIA-PACIFIC NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 268. ASIA-PACIFIC NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 269. ASIA-PACIFIC NUCLEAR MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 270. ASIA-PACIFIC NUCLEAR MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 271. ASIA-PACIFIC NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC, 2018-2023 (USD MILLION)
  • TABLE 272. ASIA-PACIFIC NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC, 2024-2030 (USD MILLION)
  • TABLE 273. ASIA-PACIFIC NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC, 2018-2023 (USD MILLION)
  • TABLE 274. ASIA-PACIFIC NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC, 2024-2030 (USD MILLION)
  • TABLE 275. ASIA-PACIFIC NUCLEAR MEDICINE MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 276. ASIA-PACIFIC NUCLEAR MEDICINE MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 277. ASIA-PACIFIC NUCLEAR MEDICINE MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 278. ASIA-PACIFIC NUCLEAR MEDICINE MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 279. AUSTRALIA NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 280. AUSTRALIA NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 281. AUSTRALIA NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PRODUCTS, 2018-2023 (USD MILLION)
  • TABLE 282. AUSTRALIA NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PRODUCTS, 2024-2030 (USD MILLION)
  • TABLE 283. AUSTRALIA NUCLEAR MEDICINE MARKET SIZE, BY PET, 2018-2023 (USD MILLION)
  • TABLE 284. AUSTRALIA NUCLEAR MEDICINE MARKET SIZE, BY PET, 2024-2030 (USD MILLION)
  • TABLE 285. AUSTRALIA NUCLEAR MEDICINE MARKET SIZE, BY SPECT, 2018-2023 (USD MILLION)
  • TABLE 286. AUSTRALIA NUCLEAR MEDICINE MARKET SIZE, BY SPECT, 2024-2030 (USD MILLION)
  • TABLE 287. AUSTRALIA NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2018-2023 (USD MILLION)
  • TABLE 288. AUSTRALIA NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2024-2030 (USD MILLION)
  • TABLE 289. AUSTRALIA NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTERS, 2018-2023 (USD MILLION)
  • TABLE 290. AUSTRALIA NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTERS, 2024-2030 (USD MILLION)
  • TABLE 291. AUSTRALIA NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY, 2018-2023 (USD MILLION)
  • TABLE 292. AUSTRALIA NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY, 2024-2030 (USD MILLION)
  • TABLE 293. AUSTRALIA NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 294. AUSTRALIA NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 295. AUSTRALIA NUCLEAR MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 296. AUSTRALIA NUCLEAR MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 297. AUSTRALIA NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC, 2018-2023 (USD MILLION)
  • TABLE 298. AUSTRALIA NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC, 2024-2030 (USD MILLION)
  • TABLE 299. AUSTRALIA NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC, 2018-2023 (USD MILLION)
  • TABLE 300. AUSTRALIA NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC, 2024-2030 (USD MILLION)
  • TABLE 301. AUSTRALIA NUCLEAR MEDICINE MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 302. AUSTRALIA NUCLEAR MEDICINE MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 303. CHINA NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 304. CHINA NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 305. CHINA NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PRODUCTS, 2018-2023 (USD MILLION)
  • TABLE 306. CHINA NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PRODUCTS, 2024-2030 (USD MILLION)
  • TABLE 307. CHINA NUCLEAR MEDICINE MARKET SIZE, BY PET, 2018-2023 (USD MILLION)
  • TABLE 308. CHINA NUCLEAR MEDICINE MARKET SIZE, BY PET, 2024-2030 (USD MILLION)
  • TABLE 309. CHINA NUCLEAR MEDICINE MARKET SIZE, BY SPECT, 2018-2023 (USD MILLION)
  • TABLE 310. CHINA NUCLEAR MEDICINE MARKET SIZE, BY SPECT, 2024-2030 (USD MILLION)
  • TABLE 311. CHINA NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2018-2023 (USD MILLION)
  • TABLE 312. CHINA NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2024-2030 (USD MILLION)
  • TABLE 313. CHINA NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTERS, 2018-2023 (USD MILLION)
  • TABLE 314. CHINA NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTERS, 2024-2030 (USD MILLION)
  • TABLE 315. CHINA NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY, 2018-2023 (USD MILLION)
  • TABLE 316. CHINA NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY, 2024-2030 (USD MILLION)
  • TABLE 317. CHINA NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 318. CHINA NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 319. CHINA NUCLEAR MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 320. CHINA NUCLEAR MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 321. CHINA NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC, 2018-2023 (USD MILLION)
  • TABLE 322. CHINA NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC, 2024-2030 (USD MILLION)
  • TABLE 323. CHINA NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC, 2018-2023 (USD MILLION)
  • TABLE 324. CHINA NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC, 2024-2030 (USD MILLION)
  • TABLE 325. CHINA NUCLEAR MEDICINE MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 326. CHINA NUCLEAR MEDICINE MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 327. INDIA NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 328. INDIA NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 329. INDIA NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PRODUCTS, 2018-2023 (USD MILLION)
  • TABLE 330. INDIA NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PRODUCTS, 2024-2030 (USD MILLION)
  • TABLE 331. INDIA NUCLEAR MEDICINE MARKET SIZE, BY PET, 2018-2023 (USD MILLION)
  • TABLE 332. INDIA NUCLEAR MEDICINE MARKET SIZE, BY PET, 2024-2030 (USD MILLION)
  • TABLE 333. INDIA NUCLEAR MEDICINE MARKET SIZE, BY SPECT, 2018-2023 (USD MILLION)
  • TABLE 334. INDIA NUCLEAR MEDICINE MARKET SIZE, BY SPECT, 2024-2030 (USD MILLION)
  • TABLE 335. INDIA NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2018-2023 (USD MILLION)
  • TABLE 336. INDIA NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2024-2030 (USD MILLION)
  • TABLE 337. INDIA NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTERS, 2018-2023 (USD MILLION)
  • TABLE 338. INDIA NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTERS, 2024-2030 (USD MILLION)
  • TABLE 339. INDIA NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY, 2018-2023 (USD MILLION)
  • TABLE 340. INDIA NUCLEAR MEDICINE MARKET SIZE, BY BRACHYTHERAPY, 2024-2030 (USD MILLION)
  • TABLE 341. INDIA NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 342. INDIA NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 343. INDIA NUCLEAR MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 344. INDIA NUCLEAR MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 345. INDIA NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC, 2018-2023 (USD MILLION)
  • TABLE 346. INDIA NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC, 2024-2030 (USD MILLION)
  • TABLE 347. INDIA NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC, 2018-2023 (USD MILLION)
  • TABLE 348. INDIA NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC, 2024-2030 (USD MILLION)
  • TABLE 349. INDIA NUCLEAR MEDICINE MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 350. INDIA NUCLEAR MEDICINE MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 351. INDONESIA NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 352. INDONESIA NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 353. INDONESIA NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PRODUCTS, 2018-2023 (USD MILLION)
  • TABLE 354. INDONESIA NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC PRODUCTS, 2024-2030 (USD MILLION)
  • TABLE 355. INDONESIA NUCLEAR MEDICINE MARKET SIZE, BY PET, 2018-2023 (USD MILLION)
  • TABLE 356. INDONESIA NUCLEAR MEDICINE MARKET SIZE, BY PET, 2024-2030 (USD MILLION)
  • TABLE 357. INDONESIA NUCLEAR MEDICINE MARKET SIZE, BY SPECT, 2018-2023 (USD MILLION)
  • TABLE 358. INDONESIA NUCLEAR MEDICINE MARKET SIZE, BY SPECT, 2024-2030 (USD MILLION)
  • TABLE 359. INDONESIA NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2018-2023 (USD MILLION)
  • TABLE 360. INDONESIA NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC PRODUCTS, 2024-2030 (USD MILLION)
  • TABLE 361. INDONESIA NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTERS, 2018-2023 (USD MILLION)
  • TABLE 362. I